2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Tuberous Sclerosis: new trials by email Literature Review of Tuberous Sclerosis trials Research Report on Tuberous Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment - Angiofibroma of Face, Tuberous Sclerosis | Phase 2 | Terminated | Aucta Pharmaceuticals, Inc | 24 | 2017-04-12 | 2025-12-01 |
| Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers Propranolol - Renal Angiomyolipomas, Tuberous Sclerosis | Phase 2 | Terminated | University Hospital, Bordeaux | 2 | 2015-05-22 | 2026-06-24 |
Erythema (1) · Exanthema (1) · Facies (1) · Fibroma (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hamartoma (2) · Heredodegenerative Disorders, Nervous System (2) · Malformations of Cortical Development (2) · Malformations of Cortical Development, Group I (2) · Neoplasms (2) · Neoplasms, Multiple Primary (2) · Neoplastic Syndromes, Hereditary (2) · Nervous System Diseases (2) · Nervous System Malformations (2) · Neurocutaneous Syndromes (2) · Neurodegenerative Diseases (2) · Disease Attributes (1)
Propranolol (1) · Sirolimus (1)
Aucta Pharmaceuticals, Inc (1) · University Hospital, Bordeaux (1)
China (1) · France (1) · United States (1)